Edition:
United States

Global Markets Headlines

Pfizer-AstraZeneca deal not quite dead yet

Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.

Photo

Wisconsin, Minnesota primaries to gauge strength of opposition to Trump

WASHINGTON States such as Wisconsin helped drive Donald Trump’s surprising presidential win two years ago, and Tuesday's primaries there and in neighboring Minnesota serve as a barometer of opposition strength headed into the November midterm elections.